LRRC19 and ovarian cancer: Interestingly, poor prognosis in ovarian cancer (OS HR = 0.77, 95% CI = 0.68 to 0.88, P=0.00013; PFS HR = 0.75, 95% CI = 0.66 to 0.87, P=8.3e − 05) and gastric cancer (OS HR = 0.72, 95% CI = 0.59 to 0.88, P=0.0013; FP HR = 0.72, 95% CI = 0.57 to 0.9, P=0.0036) was shown to correlate with lower LRRC19 expression (Figures 6(a)–6(d)).